Good Samaritan Hospital, commonly known as Good Sam, is an acute care hospital in the Cambrian district of San Jose, California, with satellite facilities in neighboring Los Gatos. It contains centers for treatment of stroke and chest pain, as well as a large maternity ward. It has been owned by HCA since 1996.

There are 474 beds in Good Samaritan Hospital.

During the past decade, Good Samaritan Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 11 clinical trials were completed, i.e. on average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Good Samaritan Hospital" #1 sponsor was "Obstetrix Medical Group" with 9 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Harvard Pilgrim Health Care" with 3 trials sponsored, "AirXpanders, Inc." with 2 trials sponsored and "Astellas Pharma Inc" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Good Samaritan Hospital" #1 collaborator was "Obstetrix Medical Group" with 3 trials as a collaborator, "Rush University" with 3 trials as a collaborator, "University of California, Irvine" with 3 trials as a collaborator, "University of Massachusetts, Amherst" with 3 trials as a collaborator and "Astellas Pharma US, Inc." with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Good Samaritan Hospital" are "Cerebrovascular Accident" (3 trials), "Preterm Delivery" (3 trials), "Breast Cancer" (2 trials), "Coronary Artery Disease" (2 trials) and "Intra-amniotic Infection" (2 trials). Many other conditions were trialed in "Good Samaritan Hospital" in a lesser frequency.

Most popular intervention types in "Good Samaritan Hospital" are "Drug" (12 trials), "Device" (9 trials), "Other" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Arm 1: Routine Care" (2 trials), "Placebo" (2 trials), "17-alpha-hydroxy-progesterone caproate, Makena®" (1 trials), "17-alpha-hydroxyprogesterone caproate injectable" (1 trials) and "AeroForm Tissue Expander" (1 trials). Other intervention names were less common.

The vast majority of trials in "Good Samaritan Hospital" are 18 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "Good Samaritan Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Good Samaritan Hospital, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Good Samaritan Hospital, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 8 trials that are defined as “Not Applicable".